Browse drugs

… restored the expression levels of both missense mutants, while CQ treatment had no significant effect, indicating that the ubiqui…

…infusions at our clinic. Among 18 patients, 8 were eligible for vericiguat, which was associated with better echocardiographic findings, i…

…imilars represent an opportunity to reduce healthcare costs. An infliximab biosimilar (b-IFX) was introduced in our hospital in 2017. Our …

…and greater VNRS reduction over time (p=0.01) compared with the lidocaine group, with a higher sedation score (p<0.01). Immediately postp…

…t-effective; FP: incremental NHB 0.00388 QALYs/person, low-dose amitriptyline dominant, 68.7% probability cost-effective).Conclusion In addit…

…odel with intravenous TCR-T cell transfer and systemic low-dose MEKi.Results MEKi co-treatment induced a more tempered activation pr…

…Objectives Methotrexate (MTX) effectively controls rheumatoid arthritis (RA) but often …

… support time in England over 5 years.Conclusion Zilucoplan and rozanolixizumab are associated with staff and patient time savings by potential…

…7%) were female, and the median (IQR) age was 55 (43–66) years. Corticosteroids were received by 71 (23%) patients at a median (IQR) of 1 (0–2)…

…12 hours for the remaining 13 days of induction therapy, versus AmBD (0.5 mg/kg/day for 14 days) as induction therapy for AIDS-assoc…

…derate for mortality and very low for hospital stay.Conclusions Levosimendan reduced short-term mortality and hospital stay compared with do…

…rotigotine, 24 mg/day of sennoside A・B calcium and 15 mg/day of suvorexant. He was not on antiplatelet or anticoagulant therapy. Vital sig…